Skip to content
PresyoGamot
Menu

Midodrine (foreign-made) in the Philippines

Quick answer

This entry is midodrine made abroad, as sold online. No midodrine product of any brand is registered with FDA Philippines (checked 2026-11-05), so it may not be sold here (RA 9711). The DOH price index has no entry for midodrine.

Strengths

Midodrine strengths

Midodrine is listed in 1 strength; none of them matches an FDA-registered product in the Philippines.

Midodrine strengths
StrengthGeneric pageRegistered here
2.5 mgMidodrine 2.5 mgno

Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.

Paying less for midodrine

  • Ask for the generic

    Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works

  • Senior or PWD card

    20% off plus no VAT on your own medicines, with ID and prescription. What to bring

Questions people ask

Is Midodrine registered with FDA in the Philippines?

No product named Midodrine appears in the FDA Philippines registry (checked 2026-11-05). No midodrine product is registered either, so it may not be sold here (RA 9711).

How much is Midodrine in the Philippines?

The DOH Drug Price Reference Index (June 2024 edition) has no entry for midodrine, so there is no official reference price. Ask two or three licensed drugstores for the price of the same strength, branded and generic.

Can I buy midodrine in the Philippines?

No midodrine product is registered with FDA Philippines (checked 2026-11-05), so no drugstore may legally sell it here (RA 9711), and products offered online are not supervised by FDA. Ask your doctor about a registered alternative.

No product named Midodrine appears in the FDA Philippines registry; neither does any product with this ingredient. A medicine that is not registered with FDA Philippines may not be sold here (RA 9711). If you are offered it, check the registration number first.

Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.